4//SEC Filing
Zaderej Karen L. 4
Accession 0001562180-24-005698
CIK 0001314102other
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 5:00 PM ET
Size
7.2 KB
Accession
0001562180-24-005698
Insider Transaction Report
Form 4
Zaderej Karen L.
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-07-11−2,000→ 2,000 totalExercise: $0.00→ Common Stock (2,000 underlying) - Exercise/Conversion
Common Stock
2024-07-11+2,000→ 4,000 total
Footnotes (1)
- [F1]The restricted stock units vests in three ratable annual installments beginning July 11, 2023.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001530968
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 5:00 PM ET
- Size
- 7.2 KB